Strides, Orbicular sign pact to jointly develop a range of nasal sprays
Express Pharma
MAY 3, 2023
Partnership to leverage Orbicular’s advanced development capabilities with Strides’ USFDA-approved manufacturing site for Nasal Sprays at Chestnut Ridge, New York Strides Pharma Science and Orbicular Pharmaceutical Technologies have entered into a strategic partnership to develop, manufacture and commercialise nasal sprays for the global markets.
Let's personalize your content